Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Precision BioSciences, Inc. (DTIL : NSDQ)
 
 • Company Description   
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.

Number of Employees: 45

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.71 Daily Weekly Monthly
20 Day Moving Average: 704,292 shares
Shares Outstanding: 62.18 (millions)
Market Capitalization: $106.32 (millions)
Beta: 1.82
52 Week High: $14.38
52 Week Low: $1.49
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -25.33% -18.24%
12 Week -60.05% -55.10%
Year To Date -76.89% -71.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
302 EAST PETTIGREW STREET SUITE A-100
-
DURHAM,NC 27701
USA
ph: 919-314-5512
fax: -
jwong@bplifescience.com http://www.precisionbiosciences.com
 
 • General Corporate Information   
Officers
Michael Amoroso - President; Chief Executive Officer and Director
John Alexander Kelly - Chief Financial Officer
Shane Barton - Vice President and Corporate Controller
Derek Jantz, - Director
Shalini Sharp - Director

Peer Information
Precision BioSciences, Inc. (CORR.)
Precision BioSciences, Inc. (RSPI)
Precision BioSciences, Inc. (CGXP)
Precision BioSciences, Inc. (BGEN)
Precision BioSciences, Inc. (GTBP)
Precision BioSciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 74019P108
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 62.18
Most Recent Split Date: (:1)
Beta: 1.82
Market Capitalization: $106.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.43 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.73 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.50
Price/Cash Flow: -
Price / Sales: 1.04
EPS Growth
vs. Year Ago Period: -39.39%
vs. Previous Quarter: -21.05%
Sales Growth
vs. Year Ago Period: -79.71%
vs. Previous Quarter: -47.67%
ROE
03/31/22 - -44.19
12/31/21 - -34.78
09/30/21 - -41.63
ROA
03/31/22 - -18.86
12/31/21 - -13.15
09/30/21 - -14.61
Current Ratio
03/31/22 - 4.61
12/31/21 - 4.50
09/30/21 - 5.02
Quick Ratio
03/31/22 - 4.61
12/31/21 - 4.50
09/30/21 - 5.02
Operating Margin
03/31/22 - -39.10
12/31/21 - -26.49
09/30/21 - -26.91
Net Margin
03/31/22 - -39.10
12/31/21 - -26.49
09/30/21 - -26.91
Pre-Tax Margin
03/31/22 - -39.10
12/31/21 - -26.49
09/30/21 - -26.91
Book Value
03/31/22 - 1.14
12/31/21 - 1.50
09/30/21 - 1.70
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.04
12/31/21 - 0.03
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 3.44
12/31/21 - 2.65
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©